Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Development of a data-driven COVID-19 prognostication tool to inform triage and step-down care for hospitalised patients in Hong Kong: A population-based cohort study

Eva L.H. Tsui, Carrie S.M. Lui, Pauline P.S. Woo, Alan T.L. Cheung, Peggo K.W. Lam, Van T.W. Tang, C.F. Yiu, C.H. Wan, Libby H.Y. Lee
doi: https://doi.org/10.1101/2020.07.13.20152348
Eva L.H. Tsui
1Statistics and Data Science, Department, Hospital Authority, Hong Kong, Address: Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: elhtsui@ha.org.hk
Carrie S.M. Lui
1Statistics and Data Science, Department, Hospital Authority, Hong Kong, Address: Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pauline P.S. Woo
1Statistics and Data Science, Department, Hospital Authority, Hong Kong, Address: Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan T.L. Cheung
1Statistics and Data Science, Department, Hospital Authority, Hong Kong, Address: Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peggo K.W. Lam
1Statistics and Data Science, Department, Hospital Authority, Hong Kong, Address: Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Van T.W. Tang
1Statistics and Data Science, Department, Hospital Authority, Hong Kong, Address: Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C.F. Yiu
1Statistics and Data Science, Department, Hospital Authority, Hong Kong, Address: Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C.H. Wan
1Statistics and Data Science, Department, Hospital Authority, Hong Kong, Address: Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Libby H.Y. Lee
2Strategy and Planning Division, Hospital Authority, Hong Kong, Address: Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background This is the first study on prognostication in an entire cohort of laboratory-confirmed COVID-19 patients in the city of Hong Kong. Prognostic tool is essential in the contingency response for the next wave of outbreak. This study aims to develop prognostic models to predict COVID-19 patients’ clinical outcome on day 1 and day 5 of hospital admission.

Methods We did a retrospective analysis of a complete cohort of 1,037 COVID-19 laboratory-confirmed patients in Hong Kong as of 30 April 2020, who were admitted to 16 public hospitals with their data sourced from an integrated electronic health records system. It covered demographic information, chronic disease(s) history, presenting symptoms as well as the worst clinical condition status, biomarkers’ readings and Ct value of PCR tests on Day-1 and Day-5 of admission. The study subjects were randomly split into training and testing datasets in a 8:2 ratio. Extreme Gradient Boosting (XGBoost) model was used to classify the training data into three disease severity groups on Day-1 and Day-5.

Results The 1,037 patients had a mean age of 37.8 (SD±17.8), 53.8% of them were male. They were grouped under three disease outcome: 4.8% critical/serious, 46.8% stable and 48.4% satisfactory. Under the full models, 30 indicators on Day-1 and Day-5 were used to predict the patients’ disease outcome and achieved an accuracy rate of 92.3% and 99.5%. With a trade-off between practical application and predictive accuracy, the full models were reduced into simpler models with seven common specific predictors, including the worst clinical condition status (4-level), age group, and five biomarkers, namely, CRP, LDH, platelet, neutrophil/lymphocyte ratio and albumin/globulin ratio. Day-1 model’s accuracy rate, macro- and micro-averaged sensitivity and specificity were 91.3%, 84.9%-91.3% and 96.0%-95.7% respectively, as compared to 94.2%, 95.9%-94.2% and 97.8%-97.1% under Day-5 model.

Conclusions Both Day-1 and Day-5 models can accurately predict the disease severity. Relevant clinical management could be planned according to the predicted patients’ outcome. The model is transformed into a simple online calculator to provide convenient clinical reference tools at the point of care, with an aim to inform clinical decision on triage and step-down care.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study received no external funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Research Ethics Committee(Kowloon Central / Kowloon East)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The de-identified datasets generated and analysed during the current study are not publicly available for patient privacy protection as their disclosure at granular level may entail the risk of subject re-identification. Aggregate data are available from the corresponding author on reasonable request. The calculator tool which is developed based on the prognostic models' results of this study will be available for online public access after the study being published.

  • List of Abbreviations

    A
    albumin
    A/G
    ratio albumin-globulin ratio
    AI
    Artificial Intelligence
    AII
    airborne infection isolation
    ALP
    alkaline phosphatase
    ALT
    alanine aminotransferase
    AST
    aspartate aminotransferase
    CMS
    Clinical Management System
    COVID-19
    Coronavirus Disease 2019
    CRP
    C-reactive protein
    ECMO
    extracorporeal membrane oxygenation
    eNID
    Electronic Notification of Infectious Disease
    G
    globulin
    HA
    Hospital Authority
    HK
    Hong Kong
    ICU
    intensive care unit
    ILI
    influenza-like illness
    LDH
    lactate dehydrogenase
    MPV
    mean platelet volume
    N/L
    ratio neutrophil-lymphocyte ratio
    NDORS
    Notifiable Diseases and Outbreak Reporting System
    PCT
    procalicitonin
    RT-PCR
    reverse-transcription polymerase chain reaction
    SARS
    Severe Acute Respiratory Syndrome
    SD
    standard deviation
    WBC
    white blood cell count
    WHO
    World Health Organization
    XGBoost
    Extreme Gradient Boosting
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
    Back to top
    PreviousNext
    Posted July 20, 2020.
    Download PDF

    Supplementary Material

    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Development of a data-driven COVID-19 prognostication tool to inform triage and step-down care for hospitalised patients in Hong Kong: A population-based cohort study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Development of a data-driven COVID-19 prognostication tool to inform triage and step-down care for hospitalised patients in Hong Kong: A population-based cohort study
    Eva L.H. Tsui, Carrie S.M. Lui, Pauline P.S. Woo, Alan T.L. Cheung, Peggo K.W. Lam, Van T.W. Tang, C.F. Yiu, C.H. Wan, Libby H.Y. Lee
    medRxiv 2020.07.13.20152348; doi: https://doi.org/10.1101/2020.07.13.20152348
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Development of a data-driven COVID-19 prognostication tool to inform triage and step-down care for hospitalised patients in Hong Kong: A population-based cohort study
    Eva L.H. Tsui, Carrie S.M. Lui, Pauline P.S. Woo, Alan T.L. Cheung, Peggo K.W. Lam, Van T.W. Tang, C.F. Yiu, C.H. Wan, Libby H.Y. Lee
    medRxiv 2020.07.13.20152348; doi: https://doi.org/10.1101/2020.07.13.20152348

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Health Informatics
    Subject Areas
    All Articles
    • Addiction Medicine (215)
    • Allergy and Immunology (495)
    • Anesthesia (106)
    • Cardiovascular Medicine (1093)
    • Dentistry and Oral Medicine (195)
    • Dermatology (141)
    • Emergency Medicine (274)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
    • Epidemiology (9757)
    • Forensic Medicine (5)
    • Gastroenterology (480)
    • Genetic and Genomic Medicine (2303)
    • Geriatric Medicine (222)
    • Health Economics (462)
    • Health Informatics (1553)
    • Health Policy (732)
    • Health Systems and Quality Improvement (602)
    • Hematology (236)
    • HIV/AIDS (501)
    • Infectious Diseases (except HIV/AIDS) (11631)
    • Intensive Care and Critical Care Medicine (616)
    • Medical Education (236)
    • Medical Ethics (67)
    • Nephrology (256)
    • Neurology (2139)
    • Nursing (134)
    • Nutrition (335)
    • Obstetrics and Gynecology (426)
    • Occupational and Environmental Health (517)
    • Oncology (1172)
    • Ophthalmology (363)
    • Orthopedics (128)
    • Otolaryngology (220)
    • Pain Medicine (145)
    • Palliative Medicine (50)
    • Pathology (309)
    • Pediatrics (694)
    • Pharmacology and Therapeutics (298)
    • Primary Care Research (265)
    • Psychiatry and Clinical Psychology (2172)
    • Public and Global Health (4645)
    • Radiology and Imaging (775)
    • Rehabilitation Medicine and Physical Therapy (455)
    • Respiratory Medicine (623)
    • Rheumatology (274)
    • Sexual and Reproductive Health (225)
    • Sports Medicine (208)
    • Surgery (250)
    • Toxicology (43)
    • Transplantation (120)
    • Urology (94)